A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages-Reference-Cited by-同舟云学术

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

Published:2014-09-28 Issue:11 Volume:16 Page:1105-1117
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Lu Haihui,Clauser Karl R.,Tam Wai Leong,Fröse Julia,Ye Xin,Eaton Elinor Ng,Reinhardt Ferenc,Donnenberg Vera S.,Bhargava Rohit,Carr Steven A.,Weinberg Robert A.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/ncb3041.pdf

Reference67 articles.

1. Huber, M. A., Kraut, N. & Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548–558 (2005).

2. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871–890 (2009).

3. Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015–1028 (2012).

4. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).

5. Morel, A. P. et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3, e2888 (2008).

Cited by 374 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention;Heliyon;2024-09

2. Intratumor heterogeneity in breast cancer: Tracing its origins and translating findings into clinical practice;Precision Medicine and Engineering;2024-09

3. Exploring the clinical and biological significance of the cell cycle-related gene CHMP4C in prostate cancer;BMC Medical Genomics;2024-08-13

4. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages;Molecular Cancer;2024-07-27

5. A common secretomic signature across epithelial cancers metastatic to the pleura supports IL-6 axis therapeutic targeting;Frontiers in Immunology;2024-07-24